結核に対するRv0976cを表現するサブユニットワクチンの保護効果
Ziwei Zhou1, Dan Chen2, Fuzeng Chen1
1State Key Laboratory of Genetic Engineering, Institute of Genetics, School of Life Science, Fudan University, Shanghai 200433, China.
Vaccines
|August 28, 2025
まとめ
Rv0976cは新しい結核ワクチンの抗原として有望である. マウスの強い細胞免疫と抗体反応を誘発し,Mycobacterium tuberculosisの挑戦から保護し,将来のワクチン開発の可能性を示唆した.
科学分野:
- 免疫学
- ワクチン学
- 微生物学
背景:
- 効果的な結核ワクチンの開発は,世界の健康にとって極めて重要です.
- 細胞免疫を誘発するサブユニットワクチンは有望な戦略です.
- 新しい免疫原性抗原を特定することは,新しいワクチン開発の鍵です.
研究 の 目的:
- サブユニットTBワクチン開発における7つの候補抗原の潜在性を検知する.
- 選択された抗原,特にRv0976cの免疫性および保護効果を評価する.
主な方法:
- マウスは精製されたタンパク質 (PPE19,PPE50,FadD21,Rv1505c,Rv1506c,Rv2035,Rv0976c) またはRv0976cを発現するDNAワクチンを接種した.
- 抗原特異的Th1細胞免疫反応とIgGレベルを評価した.
- Rv0976c DNAワクチンを接種したマウスは,保護効果を評価するために,Mycobacterium tuberculosis (M. tb) と挑戦されました.
主要な成果:
- Rv0976cは,PPE19,PPE50,FadD21と共に,強い抗原特異的Th1細胞免疫反応を誘発した.
- Ag85Aと比較して,Rv0976cはより高いIgG抗体のレベルを刺激し,TB患者の血清で反応性を示した.
- Rv0976c DNAワクチン接種は,主要な抗原と比較して,M. TBチャレンジに対する有意な保護を提供しました.
結論:
- Rv0976cは,結核ワクチンの開発に高度な保護性を持つ抗原として特定されています.
- 他の抗原とRv0976cを組み合わせ,BCGブースターまたは治療用ワクチンの使用に関するさらなる研究が必要である.
さらに関連する動画
06:32Protective Efficacy and Pulmonary Immune Response Following Subcutaneous and Intranasal BCG Administration in Mice
Published on: September 19, 2016
10.7K
06:26Author Spotlight: Optimizing CFU Determination for Efficient Assessment of TB Vaccine Efficacy and Antigen Presentation Analysis
Published on: July 28, 2023
2.4K
関連する概念動画
Pulmonary Tuberculosis V
237
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
237
Pulmonary Tuberculosis IV
202
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
202
Pulmonary Tuberculosis I
321
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
321
Pulmonary Tuberculosis II
343
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
343
Cross-reactivity
31.5K
Overview
31.5K
